{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:23:00Z","timestamp":1792174980319,"version":"4.4.0"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.critrevonc.2016.01.022","type":"journal-article","created":{"date-parts":[[2016,1,24]],"date-time":"2016-01-24T09:31:34Z","timestamp":1453627894000},"page":"190-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era"],"prefix":"10.1016","volume":"100","author":[{"given":"Suja","family":"Pillai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2771-564X","authenticated-orcid":false,"given":"Alfred K.-Y.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2016.01.022_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)80967-8","article-title":"Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription","volume":"96","author":"Agarwal","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2265.1996.tb02065.x","article-title":"Deletion analysis of the p16 tumour suppressor gene in pheochromocytoma","volume":"45","author":"Aguiar","year":"1996","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0015","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.humpath.2013.03.014","article-title":"Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers","volume":"44","author":"Alqurashi","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0020","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functionalparaganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familialparaganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1677\/ERC-10-0113","article-title":"Mutation analysis of HIF prolyl hydroxylases (PHD\/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility","volume":"18","author":"Astuti","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0035","first-page":"2298","article-title":"Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors","volume":"58","author":"Bahuau","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(90)90151-4","article-title":"The NF1 locus encodes a protein functionally related to mammalian GAP and yeastIRA proteins","volume":"63","author":"Ballester","year":"1990","journal-title":"Cell."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1096-8628(20010122)98:3<277::AID-AJMG1082>3.0.CO;2-Q","article-title":"Adrenal tumors in BRCA1\/BRCA2 mutation carriers","volume":"98","author":"Barak","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCCpatients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0055","first-page":"65","article-title":"GNAS locus and pseudohypoparathyroidism","volume":"63","author":"Bastepe","year":"2005","journal-title":"Horm. Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0060","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","article-title":"SDHAF2 mutations in familial and sporadicparaganglioma and phaeochromocytoma","volume":"11","author":"Bayley","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, inhereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0070","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paragangliomasyndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0075","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"Berra","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0080","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrc2540","article-title":"The impact of O2 availability on human cancer","volume":"8","author":"Bertout","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0085","doi-asserted-by":"crossref","first-page":"39159","DOI":"10.1074\/jbc.M006908200","article-title":"Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase","volume":"275","author":"Besset","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0028-1103123","article-title":"Clinical features of paraganglioma syndromes","volume":"19","author":"Boedeker","year":"2009","journal-title":"Skull Base."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0095","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/00313020802198010","article-title":"The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma","volume":"40","author":"Boslooper","year":"2008","journal-title":"Pathology"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00223868","article-title":"Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany : evidence for a founder effect","volume":"95","author":"Brauch","year":"1995","journal-title":"Hum. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0105","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1210\/jc.2013-2600","article-title":"Mosaicism in HIF2A-relatedpolycythemia-paraganglioma syndrome","volume":"99","author":"Buffet","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0110","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","article-title":"PGL. NET network. The succinate dehydrogenase genetic testing in a largeprospective series of patients with paragangliomas","volume":"9","author":"Burnichon","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0115","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0120","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1093\/hmg\/dds374","article-title":"Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma","volume":"21","author":"Burnichon","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0125","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadicpheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0135","doi-asserted-by":"crossref","first-page":"djv053","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-Exome sequencing identifies MDH2\u00f3as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12022-013-9269-4","article-title":"Usefulness of negative and weak-diffuse pattern of SDHBimmunostaining in assessment of SDH mutations in paragangliomas andpheochromocytomas","volume":"24","author":"Castelblanco","year":"2013","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0145","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0150","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01534708","article-title":"Germ-line chromosomallocalization of genes in chromosome 11p linkage: parathyroid hormone, beta-globin, c-Ha-ras-1, and insulin","volume":"11","author":"Chaganti","year":"1985","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0160","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0165","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.2274789","article-title":"Genetic mechanisms of tumor suppression by the human p53 gene","volume":"250","author":"Chen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0170","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma","volume":"99","author":"Clark","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"ExomeIdentifies sequencing MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0180","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1(HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in theabsence of erythrocytosis","volume":"22","author":"Comino-M\u00e9ndez","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0185","first-page":"114","article-title":"A new syndrome: mental subnormality and nasal papillomata","volume":"13","author":"Costello","year":"1977","journal-title":"Aust. Paediatr. J."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0190","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","article-title":"Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing","volume":"98","author":"Crona","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10689-013-9666-3","article-title":"MAX mutations status in Swedish patients with pheochromocytoma andparaganglioma tumours","volume":"13","author":"Crona","year":"2014","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0200","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","article-title":"Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients","volume":"52","author":"Curr\u00e1s-Freixes","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0205","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1067\/msy.2099.101376","article-title":"Screening for MEN1 mutations in patients with atypical endocrine neoplasia","volume":"126","author":"Dackiw","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0210","first-page":"310","article-title":"Mutationanalysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET\/GDNF receptor alpha complex, in sporadic phaeochromocytomas","volume":"57","author":"Dahia","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpharegulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0220","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1158\/0008-5472.CAN-05-1427","article-title":"Familial pheochromocytoma consortium. Novel pheochromocytoma susceptibility loci identified by integrative genomics","volume":"65","author":"Dahia","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning fromgenetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2004-830522","article-title":"Frequent promoter methylation oftumor-related genes in sporadic and men2-associated pheochromocytomas","volume":"113","author":"Dammann","year":"2005","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0240","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1158\/1078-0432.CCR-14-2804","article-title":"DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers","volume":"21","author":"de Cubas","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0245","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s002689900454","article-title":"Pheochromocytoma a rare cause of hypertension: long-term follow-up of 55 surgically treated patients","volume":"22","author":"Favia","year":"1998","journal-title":"World J. Surg."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0250","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.beem.2010.10.004","article-title":"Pheochromocytomas: the (pseudo)-hypoxiahypothesis","volume":"24","author":"Favier","year":"2010","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0255","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1051\/medsci\/2012286016","article-title":"[Genetics of paragangliomas and pheochromocytomas]","volume":"28","author":"Favier","year":"2012","journal-title":"Med. Sci. (Paris)"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0260","doi-asserted-by":"crossref","first-page":"e7094","DOI":"10.1371\/journal.pone.0007094","article-title":"The Warburg effect isgenetically determined in inherited pheochromocytomas","volume":"4","author":"Favier","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2012.01.009","article-title":"Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background","volume":"205","author":"Fishbein","year":"2012","journal-title":"Cancer Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0275","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations inpheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0280","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1210\/jc.2009-2170","article-title":"Isocitrate dehydrogenase mutationsare rare in pheochromocytomas and paragangliomas","volume":"95","author":"Gaal","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0285","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.378","article-title":"SDHAF1,encoding a LYR complex-II specific assembly factor, is mutated in SDH-defectiveinfantile leukoencephalopathy","volume":"41","author":"Ghezzi","year":"2009","journal-title":"Nat Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0290","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1210\/jc.2002-020525","article-title":"Functional consequences of a SDHB gene mutation in anapparently sporadic pheochromocytoma","volume":"87","author":"Gimenez-Roqueplo","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0295","first-page":"5615","article-title":"COMETE network. Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0300","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0031-1301302","article-title":"An update on the genetics of paraganglioma, phaeochromocytoma and associated hereditary syndromes","volume":"44","author":"Gimenez-Roqueplo","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0305","first-page":"6822","article-title":"Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma","volume":"60","author":"Gimm","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0310","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","article-title":"Clinical experience over 48 years with pheochromocytoma","volume":"229","author":"Goldstein","year":"1999","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0315","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.humpath.2013.11.018","article-title":"mTOR expression in colorectal adenoma-reply","volume":"45","author":"Gopalan","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0320","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Grandori","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0325","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000133336","article-title":"Sublocalization of an invasion-inducing locus and other genes on human chromosome 7","volume":"60","author":"Habets","year":"1992","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0330","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/ERC-14-0254","article-title":"Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad","volume":"21","author":"Haller","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0335","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0340","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1399-0004.2011.01653.x","article-title":"High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands","volume":"81","author":"Hensen","year":"2012","journal-title":"Clin. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0345","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1365-2826.2008.01755.x","article-title":"Analysis of selected genesin neuroendocrine tumours: insulinomas and phaeochromocytomas","volume":"20","author":"Hras\u0107an","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0304-3835(03)00456-7","article-title":"RET and neuroendocrine tumors","volume":"204","author":"Ichihara","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0355","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1073\/pnas.192342099","article-title":"Biochemical purification andpharmacological inhibition of a mammalian prolyl hydroxylase acting onhypoxia-inducible factor","volume":"99","author":"Ivan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0360","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/5.12.2023","article-title":"De novo mutation of GDNF, ligandfor the RET\/GDNFR-alpha receptor complex, in Hirschsprung disease","volume":"5","author":"Ivanchuk","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-11-0497","article-title":"The genetics of phaeochromocytoma: using clinical features to guide genetic testing","volume":"166","author":"Jafri","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0370","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ejhg.2013.128","article-title":"MEN1 syndrome with aparaganglioma","volume":"22","author":"Jamilloux","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0375","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1210\/jc.2005-2178","article-title":"Review Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?","volume":"91","author":"Jimenez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0380","doi-asserted-by":"crossref","first-page":"e9084","DOI":"10.1371\/journal.pone.0009084","article-title":"Regulation of gene expression in hepatic cells by the mammalianTarget of Rapamycin (mTOR)","volume":"5","author":"Jimenez","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0385","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.33549\/physiolres.932789","article-title":"HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors","volume":"63","author":"Jochmanov\u00e1","year":"2014","journal-title":"Physiol. Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0390","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0395","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene","volume":"54","author":"Juhlin","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0400","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm2438","article-title":"Ras oncogenes: split personalities","volume":"9","author":"Karnoub","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0405","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12022-014-9333-8","article-title":"Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature","volume":"5","author":"Kasem","year":"2014","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0415","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0420","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/386761a0","article-title":"Cancer-susceptibility genes Gatekeepers and caretakers","volume":"386","author":"Kinzler","year":"1997","journal-title":"Nature."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0425","series-title":"GeneReviews","article-title":"Hereditary paraganglioma-phaeochromocytoma syndromes","author":"Kirmani","year":"1993"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0430","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHAimmunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0435","first-page":"81","article-title":"The KRAS oncogene: past, present, and future","volume":"1756","author":"Kranenburg","year":"2005","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0440","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/1078-0432.CCR-10-0420","article-title":"SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma","volume":"17","author":"Kunst","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0445","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research source: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"L\u00f3pez-Jim\u00e9nez","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0450","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","author":"Ladroue","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0455","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/106689699300100204","article-title":"Paragangliomas: a comparative clinical, histologic and immunohistochemical study","volume":"1","author":"Lam","year":"1993","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0460","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1445-2197.1993.tb00507.x","article-title":"Paraganglioma of urinary bladder: an immunohistochemical study and report of an unusual association with intestinal carcinoid","volume":"63","author":"Lam","year":"1993","journal-title":"Aust. N. Z. J. Surg."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0465","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF02739777","article-title":"Composite pheochromocytoma-ganglioneuroma of the adrenal gland: an uncommon entity with distinctive clinicopathologic features","volume":"10","author":"Lam","year":"1999","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0470","first-page":"421","article-title":"A review of clinicopathologic features of pheochromocytomas in Hong Kong Chinese","volume":"19","author":"Lam","year":"1993","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0475","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0748-7983(95)95262-4","article-title":"Expression of p53 and its relationship with human papillomavirus in penile carcinomas","volume":"21","author":"Lam","year":"1995","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0480","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2<212::AID-IJC13>3.0.CO;2-F","article-title":"Prevalence and predictive value of p53 mutation in patients with esophageal squamous cell carcinomas: a prospective clinicopatholgical study and survival analysis of 70 patients","volume":"74","author":"Lam","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0485","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02739697","article-title":"Composite paraganglioma-ganglioneuroma of the urinary bladder: a cliniopathologic, immunohistochemical, and ultrastructural study of a case and review of the literature","volume":"9","author":"Lam","year":"1998","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0490","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5858\/2000-124-0228-ESCC","article-title":"Esophageal small cell carcinoma: clinicopathologic parameters, p53 overexpression, proliferative marker, and their impact on pathogenesis","volume":"124","author":"Lam","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0495","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jcp.54.6.443","article-title":"The clinicopathological features and importance of p53, Rb and mdm2 expression in phaeochromocytomas and paragangliomas","volume":"54","author":"Lam","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0500","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00384-008-0455-7","article-title":"hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features","volume":"23","author":"Lam","year":"2008","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0505","first-page":"105","article-title":"Update on paragangliomas and pheochromocytomas","volume":"31S1","author":"Lam","year":"2015","journal-title":"Turk. Patoloji Derg."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0510","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4137\/BCBCR.S18715","article-title":"Hereditary breast cancer: clinical, pathological and molecular characteristics","volume":"8","author":"Larsen","year":"2014","journal-title":"Breast Cancer (Auckl)."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0515","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumorsuppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0520","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1083\/jcb.200408113","article-title":"A standardized kinesin nomenclature","volume":"167","author":"Lawrence","year":"2004","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0525","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.10205","article-title":"Medullary thyroid carcinoma as part of a multiple endocrine neoplasiatype 2B syndrome: influence of the stage on the clinical course","volume":"94","author":"Leboulleux","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0530","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","article-title":"Neuronal apoptosis linked to EglN3 prolylhydroxylase and familial pheochromocytoma genes: developmental culling and cancer","volume":"8","author":"Lee","year":"2005","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0535","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Endocrine Society. Pheochromocytoma andparaganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0540","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0545","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0550","first-page":"483","article-title":"Mutations of the p53 gene in human functional adrenal neoplasms","volume":"78","author":"Lin","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0555","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/bjc.1998.177","article-title":"Mutations of K-ras oncogene in human adrenaltumours in Taiwan","volume":"77","author":"Lin","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0560","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0565","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","article-title":"A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma","volume":"91","author":"Lorenzo","year":"2013","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0570","doi-asserted-by":"crossref","first-page":"138573","DOI":"10.1155\/2015\/138573","article-title":"Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targetednext generation sequencing analysis","volume":"2015","author":"Luchetti","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0575","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/jmg.2007.051045","article-title":"Genetic screening for pheochromocytoma: should SDHC gene analysis be included","volume":"44","author":"Mannelli","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0580","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2008-2419","article-title":"Italian Pheochromocytoma\/Paraganglioma Network. Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas","volume":"94","author":"Mannelli","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0585","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated withchromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0590","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2007-0797","article-title":"Genetics of carney triad: recurrent losses at chromosome 1 but lack of germlinemutations in genes associated with paragangliomas and gastrointestinal stromaltumors","volume":"92","author":"Matyakhina","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0595","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/s00018-007-7082-2","article-title":"The role of hypoxia-inducible factors in cancer","volume":"64","author":"Maynard","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0600","first-page":"1263","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"2007","author":"McCubrey","year":"1773","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0605","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMc071191","article-title":"International carney triad and carney-stratakis syndrome consortium: familial gastrointestinal stromal tumors and germ-line mutations","volume":"357","author":"McWhinney","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0610","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/1097-0142(197711)40:5<1987::AID-CNCR2820400502>3.0.CO;2-R","article-title":"One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926\u20131976: a clinicopathological analysis","volume":"40","author":"Melicow","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0615","doi-asserted-by":"crossref","first-page":"E287","DOI":"10.1210\/jc.2014-1870","article-title":"SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma\/paraganglioma","volume":"100","author":"Menara","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0620","doi-asserted-by":"crossref","first-page":"E1661","DOI":"10.1210\/jc.2013-1636","article-title":"Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association withactivation of the HIF-1\u00f3\/miR-210 signaling pathway","volume":"98","author":"Merlo","year":"2013","journal-title":"J. Clin. Endocrinol Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0625","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0630","first-page":"257","article-title":"Malate dehydrogenases\u2013structure and function","volume":"21","author":"Min\u00e1rik","year":"2002","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0635","first-page":"1596","article-title":"Lowfrequency of ras gene mutations in neuroblastomas, pheochromocytomas, andmedullary thyroid cancers","volume":"51","author":"Moley","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0640","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/ijc.29080","article-title":"Oncometabolites-driventumorigenesis From genetics to targeted therapy","volume":"135","author":"Morin","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0645","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0022-5347(17)36397-8","article-title":"Absent ras gene mutations in humanadrenal cortical neoplasms and pheochromocytomas","volume":"149","author":"Moul","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0650","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene inmultiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0655","doi-asserted-by":"crossref","first-page":"24426","DOI":"10.1074\/jbc.M802316200","article-title":"KIF1Bbeta functions as a haploinsufficient tumorsuppressor gene mapped to chromosome 1p36: 2 by inducing apoptotic cell death","volume":"283","author":"Munirajan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0660","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0665","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/105221608786883825","article-title":"Expression of the p16INK4A\/Cdkn2a gene isprevalently downregulated in human pheochromocytoma tumor specimens","volume":"14","author":"Muscarella","year":"2008","journal-title":"Gene. Expr."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0670","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-012-9199-6","article-title":"Signaling pathways in pheochromocytomas andparagangliomas: prospects for future therapies","volume":"23","author":"N\u00f6lting","year":"2012","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0675","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","article-title":"Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus","volume":"337","author":"Neumann","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0680","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutationsin nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N. Engl. J Med."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0685","doi-asserted-by":"crossref","first-page":"E1279","DOI":"10.1210\/jc.2011-0114","article-title":"Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites","volume":"96","author":"Neumann","year":"2011","journal-title":"J. Clin .Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0690","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0695","doi-asserted-by":"crossref","first-page":"E1376","DOI":"10.1210\/jc.2013-3879","article-title":"H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series","volume":"99","author":"Oudijk","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0700","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"International symposium on pheochromocytoma. pheochromocytoma: recommendations for clinical practice from the first international symposium. October 2005","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0705","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","article-title":"New syndrome of paraganglioma andsomatostatinoma associated with polycythemia","volume":"31","author":"Pacak","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0710","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1083\/jcb.200112129","article-title":"c-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation","volume":"158","author":"Palmada","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0715","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0720","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomicanalysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0725","first-page":"370","article-title":"Multiple endocrine neoplasia, the old and the new: a mini review","volume":"33","author":"Pasquali","year":"2012","journal-title":"G Chir."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0730","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/ERC-11-0308","article-title":"The microRNA expression changes associated withmalignancy and SDHB mutation in pheochromocytoma","volume":"19","author":"Patterson","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0735","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ncpendmet0726","article-title":"Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation","volume":"4","author":"Peczkowska","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0740","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/cen.12218","article-title":"Testing newsusceptibility genes in the cohort of apparently sporadicphaeochromocytoma\/paraganglioma patients with clinical characteristics of hereditary syndromes","volume":"79","author":"Peczkowska","year":"2013","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0745","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2007-04-084434","article-title":"A novelerythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove","volume":"110","author":"Percy","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0750","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/modpathol.3801013","article-title":"Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignantpheochromocytomas","volume":"21","author":"Petri","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0755","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/ERC-11-0369","article-title":"Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients","volume":"19","author":"Piccini","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0760","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1210\/jc.2007-1989","article-title":"Paraganglioma after maternal transmission of a succinatedehydrogenase gene mutation","volume":"93","author":"Pigny","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0765","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha intumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0770","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2006-0920","article-title":"Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations","volume":"91","author":"Pollard","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0775","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility topheochromocytoma","volume":"42","author":"Qin","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0780","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/epi.23271","article-title":"ATRX: the case of a peculiar chromatin remodeler","volume":"8","author":"Ratnakumar","year":"2013","journal-title":"Epigenetics."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0785","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner topediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0790","doi-asserted-by":"crossref","first-page":"c3810","DOI":"10.1038\/sj.onc.1202737","article-title":"Tissue-specific alternative splicing in the human INK4a\/ARF cell cycle regulatory locus","volume":"18","author":"Robertson","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0795","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1097-0347(199808)20:5<374::AID-HED3>3.0.CO;2-V","article-title":"Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level","volume":"20","author":"Rodr\u00edguez-Cuevas","year":"1998","journal-title":"Head Neck"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0800","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0005-2728(01)00228-6","article-title":"Inborn errors of complex II\u2013unusual human mitochondrial diseases","volume":"1553","author":"Rustin","year":"2002","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0805","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejso.2010.10.010","article-title":"Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes","volume":"37","author":"Salajegheh","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0810","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.humpath.2013.04.014","article-title":"Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma","volume":"44","author":"Salajegheh","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0815","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3858\/emm.2010.42.7.050","article-title":"Integrative epigenomic and genomic analysisof malignant pheochromocytoma","volume":"42","author":"Sandgren","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0820","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1066896914537683","article-title":"Hereditary phaeochromocytoma","volume":"22","author":"Santos","year":"2014","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0825","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.294.16.2057","article-title":"European-American Paraganglioma Study Group. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene","volume":"294","author":"Schiavi","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0830","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1101\/gad.1648608","article-title":"The kinesin KIF1Bbeta acts downstreamfrom EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor","volume":"22","author":"Schlisio","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0835","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonansyndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0840","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1043-2760(00)00372-6","article-title":"Multiple endocrine neoplasia type 1: new clinical and basic findings","volume":"12","author":"Schussheim","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0845","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/312071a0","article-title":"Biological properties of human c-Ha-ras1 genes mutated at codon 12","volume":"312","author":"Seeburg","year":"1984","journal-title":"Nature."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0850","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0855","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0860","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers","volume":"314","author":"Sjoblom","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0865","doi-asserted-by":"crossref","first-page":"074003","DOI":"10.1088\/0957-4484\/26\/7\/074003","article-title":"The emergence of nanopores in next-generationsequencing","volume":"26","author":"Steinbock","year":"2015","journal-title":"Nanotechnology"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0870","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mce.2008.11.010","article-title":"New genes and\/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors","volume":"300","author":"Stratakis","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0875","doi-asserted-by":"crossref","first-page":"E908","DOI":"10.1210\/jc.2013-1217","article-title":"Firstreport of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome","volume":"98","author":"Taieb","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0880","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0885","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MED.0000000000000150","article-title":"Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromes","volume":"22","author":"Toledo","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0890","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Multiple leiomyoma consortium germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0895","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/381785a0","article-title":"Functional receptor for GDNF encoded bythe c-ret proto-oncogene","volume":"381","author":"Trupp","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0900","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10545-008-1042-3","article-title":"-2-Hydroxyglutaric aciduria, a disorder of metabolite repair","volume":"32","author":"Van Schaftingen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0905","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1158\/1541-7786.MCR-07-0180","article-title":"c-Myc inhibits Ras-mediated differentiation opheochromocytoma cells by blocking c-Jun up-regulation","volume":"6","author":"Vaqu\u00e9","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0910","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0092-8674(95)90470-0","article-title":"Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensoryand sympathetic neurons","volume":"82","author":"Vogel","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0915","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in afamily with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Wadt","year":"2012","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0920","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00005392-199909010-00004","article-title":"Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma","volume":"162","author":"Walther","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0925","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimerregulatedbycellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sc .U. S. A."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0930","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia-associated IDH1 and IDH2mutations is a neomorphic enzyme activity converting alphaketoglutarateto2-hydroxyglutarate","volume":"17","author":"Ward","year":"2010","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0935","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1530\/ERC-11-0170","article-title":"Genetics and clinical characteristics ofhereditary pheochromocytomas and paragangliomas","volume":"18","author":"Welander","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0940","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1093\/hmg\/dds402","article-title":"Integrativeg enomics reveals frequent somatic NF1mutations in sporadic pheochromocytomas","volume":"21","author":"Welander","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0945","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","article-title":"Rare germline mutations identified by targetednext-generation sequencing of susceptibility genes in pheochromocytoma andparaganglioma","volume":"99","author":"Welander","year":"2014","journal-title":"J. Clin. Endocrino.l Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0950","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0959-8049(95)00060-V","article-title":"The mycN\/max protein complex in neuroblastoma. Shortreview","volume":"31A","author":"Wenzel","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0955","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0960","first-page":"1702","article-title":"G protein gene mutations in patients with multiple endocrinopathies","volume":"80","author":"Williamson","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0965","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0014-4835(86)80013-6","article-title":"Multiple NADPH-producing pathways control glutathione (GSH) content in retina","volume":"43","author":"Winkler","year":"1986","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0970","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/hmg\/6.7.1051","article-title":"Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL","volume":"6","author":"Woodward","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0975","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2012.00085","article-title":"The emerging role of fumarate as an oncometabolite","volume":"2","author":"Yang","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0980","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0985","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.1079605","article-title":"Architecture of succinate dehydrogenase andreactive oxygen species generation","volume":"299","author":"Yankovskaya","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0990","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1001\/jama.2010.1830","article-title":"Spectrum and prevalenceof FP\/TMEM127 gene mutations in pheochromocytomas and paragangliomas","volume":"304","author":"Yao","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2016.01.022_bib0995","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00439-008-0553-1","article-title":"A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors","volume":"124","author":"Yeh","year":"2008","journal-title":"Hum. Genet."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib1000","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1349-7006.1992.tb02722.x","article-title":"ras mutations in endocrine tumors: mutation detection by polymerasechain reaction-single strand conformation polymorphism","volume":"83","author":"Yoshimoto","year":"1992","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib1005","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1073\/pnas.0802785105","article-title":"Activation of PI3K\/Akt and MAPK pathways regulates Myc mediated transcription by phosphorylating and promoting the degradation ofMad1","volume":"105","author":"Zhu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2016.01.022_bib1010","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816300221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816300221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T02:40:34Z","timestamp":1748745634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842816300221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":202,"alternative-id":["S1040842816300221"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.022","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.728731490.793550568","asserted-by":"object"}]},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}